Astellas Pharma Inc. to Fund LabCentrals Future Innovator Prize
Astellas Pharma Inc. has partnered with LabCentral – a launchpad for early stage life science startups – to fund and encourage innovation in the industry. Through their subsidiary, Astellas Venture Management LLC, they will collaborate on the “Future Innovator Prize” which goes towards entrepreneurial scientists. The prize goes beyond funding, offering one-year usage of LabCentral’s state-of-the-art facility in Cambridge and access to Astellas’ R&D capabilities and business leaders.
Collaborations like this provide the chance for startups to fund and engage in R&D to advance the industry. Companies can submit their proposals until September 13, at which point they will be reviewed by a selection committee. 5 finalists will be selected to pitch in front of Astellas senior leadership on October 28th. Of these, the prize will be awarded to two pioneering scientists with innovative research that complements Astellas’ areas of interests, including oncology, immunology, and neuroscience.
Are you developing new software for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.